High-throughput metagenomics analysis in early and precise diagnosis of eosinophilic meningoencephalitis complicated with respiratory failure: A case report

Medicine (Baltimore). 2023 May 12;102(19):e33683. doi: 10.1097/MD.0000000000033683.

Abstract

Rationale: Human infection with Angiostrongylus cantonensis is uncommon and has only been sporadically reported in the literature. Patients infected with A cantonensis usually have a delayed diagnosis and sometimes a poor prognosis.

Patient concerns: A 70-year-old woman presented to the respiratory department with complaints of headache, chest pain, myalgia, fatigue, and anorexia for 7 days.

Diagnoses: Complete blood count showed eosinophilia. The serum was tested showing a positive finding of A cantonensis antibody. Cerebrospinal fluid was tested using high-throughput metagenomics analysis and 16 reads for A cantonensis were mapped. The patient was diagnosed with A cantonensis infection.

Interventions: The patient received a 7-day course of albendazole and 4-day course of prednisone.

Outcomes: When discharged from the hospital, the patient still suffered from fatigue and poor memory. Aminotransferase levels were high due to albendazole's liver toxicity. In a post-discharge follow-up about 1 month later she had recovered completely both physically and mentally, and peripheral eosinophil count and aminotransferase levels were both normal.

Lessons: Because the direct identification of parasites is difficult, high-throughput metagenomics analysis may provide a reliable alternative tool for the diagnoses of infection with A cantonensis. When albendazole is prescribed, caution must be taken with respect to its liver toxicity.

Publication types

  • Case Reports

MeSH terms

  • Aftercare
  • Aged
  • Albendazole / therapeutic use
  • Angiostrongylus cantonensis*
  • Animals
  • Antibodies
  • Female
  • Humans
  • Meningitis* / diagnosis
  • Meningoencephalitis* / complications
  • Meningoencephalitis* / diagnosis
  • Meningoencephalitis* / drug therapy
  • Metagenomics
  • Patient Discharge
  • Respiratory Insufficiency* / complications

Substances

  • Albendazole
  • Antibodies